Abstract:Background DNA copy number alterations are frequently observed in ovarian cancer, but it remains a challenge to identify the most relevant alterations and the specific causal genes in those regions. Methods We obtained high-resolution 500K SNP array data for 52 ovarian tumors and identified the most statistically significant minimal genomic regions with the most prevalent and highest-level copy number alterations (recurrent CNAs). Within a region of recurrent CNA, comparison of expression levels in tumors with a given CNA to tumors lacking that CNA and to whole normal ovary samples was used to select genes with CNA-specific expression patterns. A public expression array data set of laser capture micro-dissected (LCM) non-malignant fallopian tube epithelia and LCM ovarian serous adenocarcinoma was used to evaluate the effect of cell-type mixture biases. Results Fourteen recurrent deletions were detected on chromosomes 4, 6, 9, 12, 13, 15, 16, 17, 18, 22 and most prevalently on X and 8. Copy number and expression data suggest several apoptosis mediators as candidate drivers of the 8p deletions. Sixteen recurrent gains were identified on chromosomes 1, 2, 3, 5, 8, 10, 12, 15, 17, 19, and 20, with the most prevalent gains localized to 8q and 3q. Within the 8q amplicon, PVT1 , but not MYC , was strongly over-expressed relative to tumors lacking this CNA and showed over-expression relative to normal ovary. Likewise, the cell polarity regulators PRKCI and ECT2 were identified as putative drivers of two distinct amplicons on 3q. Co-occurrence analyses suggested potential synergistic or antagonistic relationships between recurrent CNAs. Genes within regions of recurrent CNA showed an enrichment of Cancer Census genes, particularly when filtered for CNA-specific expression. Conclusion These analyses provide detailed views of ovarian cancer genomic changes and highlight the benefits of using multiple reference sample types for the evaluation of CNA-specific expression changes.

Copy number alterations: a catastrophic orchestration of the breast cancer genome

Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer

Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors

Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer

Understanding the functional impact of copy number alterations in breast cancer using a network modeling approach

The landscape of somatic copy-number alteration across human cancers

High-Resolution Genomic And Expression Analyses Of Copy Number Alterations In Breast Tumors

Copy Number Aberrations from Affymetrix SNP 6.0 Genotyping Data-How Accurate Are Commonly Used Prediction Approaches?

The Repertoire of Copy Number Alteration Signatures in Human Cancer

Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors

Single-cell sequencing deciphers a convergent evolution of copy number alterations from primary to circulating tumor cells.

Genome-wide Somatic Copy Number Alteration Analysis and Database Construction for Cervical Cancer.

Somatic Gene Copy Number Alterations in Colorectal Cancer: New Quest for Cancer Drivers and Biomarkers

Systematic Modeling of Risk-Associated Copy Number Alterations in Cancer

The Landscape of Somatic Copy Number Alterations in Head and Neck Squamous Cell Carcinoma

Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors

Functional exploration of copy number alterations in a Drosophila model of triple-negative breast cancer

Signatures of copy number alterations in human cancer

Loss of chromosome cytoband 13q14.2 orchestrates breast cancer pathogenesis and drug response

High-resolution Analysis of Copy Number Alterations and Associated Expression Changes in Ovarian Tumors.

Identification of Copy Number Alterations and Its Association with Pathological Features in Clear Cell and Papillary RCC.